Cerus | CERS - Des Atouts





Des Atouts Changement Date
Cerus USD 221.86M 6.67M 2025-12
GRIFOLS EUR 20.28B 191M 2026-09
Haemonetics USD 2.41B 45.2M 2026-09
Neogen USD 3.3B 42.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Plus Therapeutics USD 14.03M 5.89M 2026-06
Quidel USD 5.78B 66M 2026-09
Rockwell Medical USD 52.62M 1.34M 2025-06
STAAR Surgical USD 485.16M 9.95M 2026-09
Terumo JPY 2.37T 61.86B 2026-06
Utah Medical Products USD 124.38M 1.84M 2026-03